Drug Discovery Featured Articles & Applications

  1. Buffer Management Solutions For Large-Scale Bioprocessing
    2/1/2018

    How outsourcing and technologies such as in-line conditioning (IC) and in-line dilution (ILD) can help prevent resource constraints, save time, and reduce manufacturing footprint and overall cost in buffer preparation.

  2. Complex Molecule Development: Early Considerations To Avoid Failing Later?
    1/26/2018

    How to understand and prepare for challenges early in development to avoid bottlenecks that significantly slow production and delay a drug’s time-to-market.

  3. Purification Workflow For The Production of Highly Pure Recombinant Proteins
    1/24/2018

    This robust purification process provides the product quality, productivity, and economics demanded by today’s downstream manufacturing.

  4. Isolation Of Individual Cells For Single-Cell Analysis
    1/24/2018

    A demonstration of a simple workflow to verify the reliability of the S3e Cell Sorter in sorting single cells.

  5. Automated mAb Workflows: Combining Multidimensional (Multi-D) Purifications With Product Analysis
    1/24/2018

    A demonstration of the development of a robust, high-quality, and automated Multi-D chromatography purification utilizing both tandem and multi-column configurations using ChromLab™ Software on an NGC Chromatography System.

  6. Are You Ready For The Future of Biomanufacturing?
    1/19/2018

    As novel medicines become a larger part of the industry's portfolio, it is critical you secure a supply chain and manufacturing processes that produce drugs in a reliable, cost-effective way. 

  7. What’s New in U.S. Biosimilar-Land?
    1/16/2018

    A lot has been promised with the introduction of biosimilars, but can they really deliver a viable alternative treatment to biologics at a substantial savings?

  8. An Innovative Solution To Flexibly Meet Unique Primary Packaging Requirements
    1/4/2018

    A customer enlisted Catalent to support their child-resistant blister packaging requirements for a global Phase III study. A flexible design was created with an integrated blister card that could also support larger study requirements of 1.9 million monthly dosing cards. Through customized commercial blistering equipment a solution was provided that would accommodate the customer’s growing demands for clinical supplies.

  9. Scalable Strategies For Parenteral Dosage Form Selection
    12/29/2017

    Understand the strategies which can be employed at the different stages of development when choosing parenteral dosage forms.

     

  10. WuXi Biologics Creates Next-Generation Continuous Manufacturing Platform
    12/20/2017

    Many biologics companies will partner with a contract development and manufacturing organization that can provide the required expertise and resources as well as flexibility of operations.